NASDAQ Rheumatology Market News
Apricus Biosciences Enters Into License Agreement With Allergan for the U.S. Rights to Vitaros(TM)
SAN DIEGO, Sept. 10, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...
Summit Therapeutics Appoints Ralf Rosskamp, MD, as Chief Medical Officer
OXFORD, United Kingdom, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), ...
Apricus Biosciences to Present at the Rodman & Renshaw 17th Annual Global Investment Conference
SAN DIEGO, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...
Medical Laser Systems Market to Benefit from Increasing Approvals from FDA: Transparency Market Research
Albany - NY, Oct. 20, 2015 (GLOBE NEWSWIRE) -- Transparency Market Research (TMR) report ...
MediciNova to Initiate Clinical Trial of MN-001 (tipelukast) in IPF
LA JOLLA, Calif., Oct. 09, 2015 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company ...
Five Prime Therapeutics Announces The Presentation of Preliminary FPA008 Phase 1 Trial Data in Rheumatoid Arthritis Patients at the 2015 ACR Annual Meeting
SOUTH SAN FRANCISCO, Calif., Oct. 7, 2015 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. ...
Tonix Pharmaceuticals Announces Acceptance of Three Abstracts to be Presented at the 2015 ACR/ARHP Annual Meeting
NEW YORK, Oct. 1, 2015 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix"), ...
Apricus Biosciences and Ferring Pharmaceuticals Sign Exclusive Distribution Agreement to Market Topical Erectile Dysfunction Cream Vitaros(TM) in Latin American Countries
SAN DIEGO, Oct. 1, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...
Apricus Biosciences Announces Corporate Update and Third Quarter 2015 Financial Results Conference Call
SAN DIEGO, Nov. 2, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...
Anthera Pharmaceuticals Announces Presentation at Healthcare Conferences, ACR Reception and Timing of Third Quarter Financial Results
HAYWARD, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) today announced the ...
American College of Rheumatology Rolls Out Lupus Education for Providers & Patients in more than 25 States Nationwide
ATLANTA, Oct. 28, 2015 (GLOBE NEWSWIRE) -- The Centers for Disease Control and Prevention ...
Apricus Biosciences Completes Enrollment in Phase 2b Clinical Trial for Fispemifene in Men with Symptomatic Secondary Hypogonadism
SAN DIEGO, Oct. 28, 2015 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...
Crescendo Bioscience Highlights New Studies With Vectra(R) DA That Will Be Presented at the American College of Rheumatology 2015 Annual Meeting
SALT LAKE CITY, Oct. 22, 2015 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a wholly-owned subsidiary ...